Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 19.80
0.00 (0.00%)
Apr 1, 2026, 12:24 PM CET
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 474.83 million as of April 2, 2026. Its market cap has increased by 29.87% in one year.
Market Cap
474.83M
Enterprise Value
608.90M
Revenue
565.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.80
Market Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 474.83M, an increase of 325.11%. That is a compound annual growth rate of 7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 474.83M | -16.81% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.91B |
| Circio Holding ASA | 2.32B |
| Nordhealth AS | 2.21B |
| Thor Medical ASA | 1.77B |
| Vistin Pharma ASA | 971.15M |
| Omda AS | 820.31M |
| Lytix Biopharma AS | 799.76M |
| Gentian Diagnostics ASA | 601.47M |